Browse Drug Recalls
25 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 25 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 25 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Mar 25, 2013 | Hydroxyprogesterone CAPR.(G.S.), compounded by Pallimed Solutions Pharmacy, W... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with qu... | Class II | Pallimed Solutions |
| Mar 25, 2013 | MIC with B6 and B12, compounded by Pallimed Solutions Pharmacy, Woburn, MA | Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with qu... | Class II | Pallimed Solutions |
| Mar 25, 2013 | Diazepam Injectable, compounded by Pallimed Solutions Pharmacy, Woburn, MA | Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with qu... | Class II | Pallimed Solutions |
| Mar 25, 2013 | Testosterone Cypionate/Testosterone Enanthate Injection, compounded by Pallim... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with qu... | Class II | Pallimed Solutions |
| Mar 25, 2013 | Atropine Injection, compounded by Pallimed Solutions Pharmacy, Woburn, MA | Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with qu... | Class II | Pallimed Solutions |
| Mar 25, 2013 | DMSO Aqueous Irrigation 50%, compounded by Pallimed Solutions Pharmacy, Wobu... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with qu... | Class II | Pallimed Solutions |
| Mar 25, 2013 | Dexamethasone PF, compounded by Pallimed Solutions Pharmacy, Woburn, MA | Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with qu... | Class II | Pallimed Solutions |
| Mar 25, 2013 | Verapamil Injection, compounded by Pallimed Solutions Pharmacy, Woburn, MA | Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with qu... | Class II | Pallimed Solutions |
| Mar 25, 2013 | Tacrolimus Ophthalmic, Pallimed Solutions Pharmacy, Woburn, MA | Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with qu... | Class II | Pallimed Solutions |
| Mar 25, 2013 | Quadmix Injection, compounded by Pallimed Solutions Pharmacy, Woburn, MA | Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with qu... | Class II | Pallimed Solutions |
| Mar 25, 2013 | Cidofovir Opthalmic Solution, compounded by Pallimed Solutions Pharmacy, Wobu... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with qu... | Class II | Pallimed Solutions |
| Mar 25, 2013 | Methylcobalamin PF, compounded by Pallimed Solutions Pharmacy, Woburn, MA | Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with qu... | Class II | Pallimed Solutions |
| Mar 25, 2013 | BiMix Injection, compounded by Pallimed Solutions Pharmacy, Woburn, MA | Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with qu... | Class II | Pallimed Solutions |
| Mar 25, 2013 | Cyclosporine Ophthalmic, compounded by Pallimed Solutions Pharmacy, Woburn, MA | Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with qu... | Class II | Pallimed Solutions |
| Mar 25, 2013 | Trimix Injection, compounded by Pallimed Solutions Pharmacy, Woburn, MA | Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with qu... | Class II | Pallimed Solutions |
| Mar 25, 2013 | Testosterone Cypionate Injection,compounded by Pallimed Solutions Pharmacy, W... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with qu... | Class II | Pallimed Solutions |
| Mar 25, 2013 | Nandrolone Decanoate Injectable, compounded by Pallimed Solutions Pharmacy, W... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with qu... | Class II | Pallimed Solutions |
| Mar 25, 2013 | Buprenorphine HCl Veterinary Injection, compounded by Pallimed Solutions Pha... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with qu... | Class II | Pallimed Solutions |
| Mar 25, 2013 | Testosterone Cypionate/Propionate Injection, compounded by Pallimed Solutions... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with qu... | Class II | Pallimed Solutions |
| Mar 25, 2013 | Acetylcysteine Ophthalmic Solution, compounded by Pallimed Solutions Pharmacy... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with qu... | Class II | Pallimed Solutions |
| Mar 25, 2013 | Bacteriostatic Water for Injection, compounded by Pallimed Solutions Pharmacy... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with qu... | Class II | Pallimed Solutions |
| Mar 25, 2013 | Gentamicin Sulfate Irrigation, compounded by Pallimed Solutions Pharmacy, Wob... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with qu... | Class II | Pallimed Solutions |
| Mar 25, 2013 | Alprostadil IN NS Injection, compounded by Pallimed Solutions Pharmacy, Wobur... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with qu... | Class II | Pallimed Solutions |
| Mar 25, 2013 | Vancomycin Ophthalmic PF, compounded by Pallimed Solutions Pharmacy, Wobrun, MA | Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with qu... | Class II | Pallimed Solutions |
| Mar 25, 2013 | HCG Chorionic Gonadotropin, compounded by Pallimed Solutions Pharmacy, Woburn... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with qu... | Class II | Pallimed Solutions |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.